BOKF vs BPOP

BOKF exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows strong recent earnings growth (YoY EPS +17%, Q/Q +11.7%) and beats earnings estimates in 3 of the last 4 quarters, supporting its current valuation above the Graham Number of $141.93. Profit margins and ROA are solid for the banking sector, but missing data on key leverage and liquidity ratios, along with insider selling, raise caution. The stock trades near analyst target ($134.30) with mixed technicals and low insider sentiment, warranting a cautious hold despite attractive yield and growth.

BPOP's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, the lack of Altman Z-Score and missing key financial data (Debt/Equity, cash/debt levels) limits confidence in structural safety. The stock trades below analyst target and intrinsic value estimates but faces headwinds from bearish insider activity and weakening technical momentum. Solid dividend coverage and sector-leading earnings surprises provide offsetting positives.